| Role |
Name |
Disclosure |
Details |
| Author | Stanley A Brosman, MD, Clinical Professor, Department of Urology, University of California at Los Angeles Medical School | Nothing to disclose | Details | | Coauthor | Mark A Moyad, MD, MPH, ND, Phil F Jenkins Director of Complementary and Alternative Medicine, Department of Urology, University of Michigan Medical Center | Nothing to disclose | Details | | Medical Editor | Gamal Mostafa Ghoniem, MD, FACS, Fellowship Program Director, Clinical Professor of Surgery, Head, Section of Voiding Dysfunction, Female Urology and Reconstruction, Cleveland Clinic Florida | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Martin I Resnick, MD , Former Lester Persky Professor and Chair, Department of Urology, Former Professor, Department of Oncology, Case Western Reserve University School of Medicine | Nothing to disclose | Details | | CME Editor | J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center | Terumo Corporation Omeros Corporation | Details | | Chief Editor | Edward David Kim, MD, FACS, Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center | Lilly | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Mark A Moyad, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Gamal Mostafa Ghoniem, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Martin I Resnick, Managing Editor |
The contributor discloses no conflict of interest. |
|